MIT Technology Review March 10, 2023
But at a global genome-editing summit, exciting trial results were tempered by safety and ethical concerns.
I’ve spent the last few days thinking about how, when, and if we should use gene-editing tools to change the human genome. These are huge questions, and very emotive ones—especially when it comes to editing embryos.
I watched scientists, ethicists, patient advocacy groups, and others wrestle with these topics at the Third International Summit on Human Genome Editing in London earlier this week.
There’s plenty to get excited about when it comes to gene editing. In the decade since scientists found they could use CRISPR to edit...